Cholinesterase inhibitors in dementia with Lewy bodies—a comparative analysis
- 30 January 2007
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 22 (9), 890-895
- https://doi.org/10.1002/gps.1759
Abstract
Objective To compare efficacy of different cholinesterase inhibitors (ChEIs) for treating patients with dementia with Lewy bodies (DLB). Design Retrospective comparison of three independent clinical studies of ChEI treatment using donepezil, galantamine or rivastigmine in patients with DLB. Method Data was obtained from open label trials of donepezil and galantamine and a placebo controlled randomized trial of rivastigmine in DLB. Changes in Mini Mental State Examination (MMSE), Neuropsychiatric Inventory (NPI) and United Parkinson's Disease Rating Scale (UPDRS‐III) scores were compared between the three treatments at 12 and 20 weeks. Results All ChEIs significantly improved cognitive and neuropsychiatric measures. Reduction in the total NPI score appeared significantly greater after donepezil treatment. There was no significant increase in UPDRS‐III scores. Conclusions It is unclear to what extent these findings reflect true differences between ChEIs or are due to methodological artefacts of comparing different studies. There is so far no compelling evidence that any one ChEI is better than the other in treating DLB but head to head comparative studies of different ChEIs are warranted to clarify this. Copyright © 2007 John Wiley & Sons, Ltd.This publication has 21 references indexed in Scilit:
- Irreversible motor impairment in young addicts ? ephedrone, manganism or both?Acta Neurologica Scandinavica, 2007
- A systematic review of prevalence and incidence studies of dementia with Lewy bodiesAge and Ageing, 2005
- A comparison of the efficacy of donepezil in Parkinson's disease with Dementia and Dementia with Lewy bodiesInternational Journal of Geriatric Psychiatry, 2005
- Role of Cholinesterase Inhibitors in Parkinson’s Disease and dementia with Lewy BodiesJournal of Geriatric Psychiatry and Neurology, 2004
- O1-05-08 Galantamine in the treatment of dementia with Lewy bodies: an interim 24 week assessmentNeurobiology of Aging, 2004
- Regulation of attention and response to therapy in dementia by butyrylcholinesterasePharmacogenetics, 2003
- Donepezil for Alzheimer's Disease: Pharmacodynamic, Pharmacokinetic, and Clinical ProfilesCNS Drug Reviews, 2001
- Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2001
- The Neuropsychiatric InventoryNeurology, 1994
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975